全球磁浮血液帮浦市场总规模（依产品类型、流量模式、应用和最终用户划分），2026-2032年预测

预计到 2025 年，磁浮血液帮浦市场总值将达到 20 亿美元，到 2026 年将成长至 21.6 亿美元，到 2032 年将达到 33.5 亿美元，年复合成长率为 7.64%。

关键市场统计数据
基准年 2025	20亿美元
预计年份：2026年	21.6亿美元
预测年份 2032	33.5亿美元
复合年增长率 (%)	7.64%

简要介绍完整的磁浮血液帮浦系统及其临床工程基础，包括影响其性能和治疗效用。

本执行摘要介绍了一种新型机械循环辅助装置－全磁浮血液帮浦技术。该技术以非接触式磁浮技术取代了传统的接触式轴承，从而最大限度地减少了摩擦、血液损伤和血液相容性风险。该技术整合了先进的转子控制、高精度感测器和优化的流路几何结构，可在各种临床场景下实现稳定的血液动力学。因此，它引起了致力于延长安全支持时间和提高患者生活质量，同时减少溶血、血栓症和装置相关感染等併发症的临床团队的关注。

控制系统、临床预期和监管实践的同步进步如何重塑磁浮血液帮浦的普及路径

近年来，临床需求与技术能力的融合带来了变革性的改变，重塑了血液帮浦技术的模式。感测器小型化和封闭回路型控制技术的进步使得磁浮系统能够以亚毫秒级的响应时间运行，从而拓展了其应用范围，从短期的术中应用扩展到更长期的体外循环和植入场景。同时，临床医师日益重视血液相容性和以患者为中心的治疗效果，也促使设计重点转向降低血液压力、简化抗凝血治疗以及提高床边操作的便利性。

因应2025年关税变化的策略措施将改变血液帮浦供应链的采购、製造韧性和成本结构。

2025年前后，美国不断变化的关税环境为在全球供应链中营运的製造商和采购团队带来了新的策略复杂性。关税调整将影响通常从多个司法管辖区采购的零件（例如精密磁铁、特殊轴承和电子控制模组）的到岸成本结构。因此，设备开发商正在重新评估筹资策略，以在控製成本的同时，维持高品质的供应链，并降低生产连续性风险。

多维分割分析揭示了跨应用、最终使用者和流程架构的关键设计问题和临床证据优先事项。

細項分析揭示了不同临床应用领域、最终用户和流程架构下细緻入微的需求和设计要务。临床应用以应用为导向，涵盖了成人、新生儿和儿童患者的心肺体外迴圈场景、静脉-动脉和静脉-静脉体外膜肺氧合（ECMO）设置，以及用于双心室、左心室和右心室支持需求的心室辅助装置（VAD）。为了因应这些差异，需要可扩展的帮浦架构、自适应控制方案和个人化的血液相容性策略，以满足不同年龄和生理特征的需求。

三大主要区域的监管环境、临床基础设施和采购生态系统如何驱动不同区域的实施策略

区域趋势正在以不同的方式影响美洲、欧洲、中东和非洲以及亚太地区的临床应用、监管策略和供应链决策。在美洲，集中分布的专业心臟中心和完善的医保报销系统支援了早期临床应用和器械迭代，而商业团队通常与大规模医院网路密切合作，推动试点部署和上市后监测。该地区强大的临床基础设施有助于快速累积器械迭代所需的真实世界数据。

竞争优势源自于现有企业的规模、专注的创新以及整合硬体、软体和临床支援能力的合作伙伴关係之间的伙伴关係。

此技术领域的竞争格局呈现出多元化的特点，既有成熟的医疗设备製造商，也有专注于帮浦技术的创新企业，还有致力于将磁浮技术的最新进展转化为临床可行平台的敏捷型新创公司。Start-Ups企业利用其规模、广泛的临床关係和监管经验，将磁浮模组整合到现有产品系列中；而规模较小、小规模专注于特定领域的公司则倾向于透过创新的转子几何形状、控制软体和感测器融合技术来突破设计界限。在整个产业中，产学合作加速了临床检验，并有助于降低早期应用风险。

制定可执行的策略重点，整合产品设计、实证规划和供应链韧性，以推动产品应用并产生长期临床影响。

行业领导者应优先考虑整合式方法，将工程选择与实证医学证据产生和报销策略相结合，以最大限度地提高临床应用率和长期影响。首先，产品开发蓝图应在设计週期的早期阶段就纳入血液相容性测试、耐久性通讯协定和实际应用性能终点，以减少后续监管方面的阻力。其次，采购和供应链团队应制定双源采购策略，并对关税敏感型组件的替代供应商进行资格审核，以维持生产的连续性和可预测的单位经济效益。

采用混合方法，结合原始临床资料收集、技术检验和多源综合分析，以产生可操作的实证研究结果。

本调查方法采用混合方法，强调一手临床数据、技术检验和多源资讯整合，确保获得可靠的实务知识。一手研究包括与循环系统医生、心臟科医生、生物医学工程师、医院采购人员和监管专家进行结构化访谈和研讨会，以了解实际应用中的性能要求、实施障碍和相关的临床终点。除这些定性研究结果外，还对设备结构、控制策略和血液相容性评估进行了技术审查，以评估技术权衡和失效模式。

整合临床和工程方面的必要因素，从而为从技术可行性到永续的临床和营运价值提供清晰的路径。

总之，全磁浮血泵技术为减少血液损伤、延长设备寿命以及拓展临床应用范围提供了一条极具前景的途径。先进的控制电子技术、精密的流路几何结构以及材料科学的进步，使得血泵的设计能够满足成人、新生儿和儿童患者在心肺体外迴圈、体外氧合和心室辅助装置等应用场景中的多样化需求。因此，这项技术有望对术中和长期机械循环支持策略产生深远影响。

目录

第一章：序言

第二章调查方法

• 研究设计
• 研究框架
• 市场规模预测
• 数据三角测量
• 调查结果
• 调查前提
• 调查限制

第三章执行摘要

• 首席体验长观点
• 市场规模和成长趋势
• 2025年市占率分析
• FPNV定位矩阵，2025
• 新的商机
• 下一代经营模式
• 产业蓝图

第四章 市场概览

• 产业生态系与价值链分析
• 波特五力分析
• PESTEL 分析
• 市场展望
• 上市策略

第五章 市场洞察

• 消费者洞察与终端用户观点
• 消费者体验基准
• 机会地图
• 分销通路分析
• 价格趋势分析
• 监理合规和标准框架
• ESG与永续性分析
• 中断和风险情景
• 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 按产品类型分類的磁浮血液帮浦市场总规模

• 心室辅助装置
  • 左心室辅助装置
  • 右心辅助装置
  • 双心室辅助装置
• 全人工心臟系统
• 儿童辅助设备
• 短期循环支援泵

第九章 依流量模式分類的磁浮血液帮浦市场总量

• 连续流
  • 轴流式
  • 离心式
  • 混合流
• 间歇性流量
• 脉动流
  • 双腔体
  • 单人房

第十章 按应用分類的磁浮血液帮浦市场总规模

• 心肺体外迴圈
  • 成人
  • 新生
  • 儿童
• 体外膜氧合器
  • 静脉-动脉
  • 静脉-静脉
• 心室辅助装置
  • 双侧心室
  • 左心室
  • 右心室

第十一章 依最终用户分類的磁浮血液帮浦市场总规模

• 门诊手术中心
• 医院
  • 心臟专科医院
  • 一般的
  • 教育
• 研究所

第十二章 各地区磁浮血液帮浦市场概况

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十三章 按组别分類的磁浮血液帮浦市场总览

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十四章 各国磁浮血液帮浦市场概况

• 我们
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

15. 美国磁浮血液帮浦市场总规模

第十六章：中国磁浮血液帮浦市场概况

第十七章 竞争格局

• 市场集中度分析，2025年
  • 浓度比（CR）
  • 赫芬达尔-赫希曼指数 (HHI)
• 近期趋势及影响分析，2025 年
• 2025年产品系列分析
• 基准分析，2025 年
• Abbott Laboratories
• Abiomed, Inc.
• Berlin Heart
• BiVACOR Inc.
• EUROSETS
• Getinge AB
• Levitronix, Inc.
• LivaNova PLC
• magAssist Co., Ltd.
• Medos Medizintechnik AG
• Medtronic plc
• Nikkiso Co., Ltd.
• ReliantHeart, Inc.
• Sun Medical Technology Research Corp.
• Suzhou Tongxin Medical
• Terumo Corporation

The Fully Magnetically Levitated Blood Pump Market was valued at USD 2.00 billion in 2025 and is projected to grow to USD 2.16 billion in 2026, with a CAGR of 7.64%, reaching USD 3.35 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 2.00 billion
Estimated Year [2026]	USD 2.16 billion
Forecast Year [2032]	USD 3.35 billion
CAGR (%)	7.64%

A concise orientation to fully magnetically levitated blood pump systems and their clinical engineering foundations that shape performance and therapeutic utility

This executive summary introduces fully magnetically levitated blood pump technology, an emergent class of mechanical circulatory support devices that replaces traditional contact bearings with noncontact magnetic suspension to minimize friction, blood trauma, and hemocompatibility risks. The technology integrates advanced rotor control, high-precision sensors, and optimized flow geometries to deliver stable hemodynamics across diverse clinical scenarios. As a result, it has attracted attention from clinical teams focused on reducing complications such as hemolysis, thrombosis, and device-related infection, while improving duration of safe support and patient quality of life.

The introduction contextualizes the technology within contemporary cardiovascular care pathways and device lifecycles. It highlights the cross-disciplinary engineering advances-magnetic actuation, control algorithms, and materials science-as well as the clinical imperatives driving adoption. With those foundations, readers will better appreciate how design choices influence clinical performance, regulatory strategy, and commercial positioning across hospitals, ambulatory settings, and research environments.

How concurrent advances in control systems, clinical expectations, and regulatory practice are reshaping adoption pathways for magnetically levitated blood pumps

Recent years have seen transformative shifts that are recalibrating the landscape for blood pump technologies, driven by convergence of clinical need and technological capability. Advances in sensor miniaturization and closed-loop control have enabled magnetic levitation systems to operate with submillisecond responsiveness, expanding their applicability from short intraoperative use to longer-term extracorporeal and implantable scenarios. Concurrently, growing clinician emphasis on hemocompatibility and patient-centered outcomes has elevated design priorities toward reduced blood trauma, simplified anticoagulation regimens, and enhanced ease of use at the point of care.

In parallel, regulatory pathways and reimbursement discussions have evolved to accommodate novel device architectures, prompting manufacturers to embed robust clinical evidence generation strategies early in development. Strategic partnerships between device engineers, clinical research sites, and specialty hospitals have accelerated iterative testing cycles, while new service models and remote monitoring capabilities are reshaping post-market surveillance and device lifecycle management. These shifts collectively favor technologies that demonstrate consistent performance across applications and end users, creating an environment conducive to broader adoption of magnetically levitated blood pumps.

Strategic operational responses to 2025 tariff shifts that are altering sourcing, manufacturing resilience, and cost structures for blood pump supply chains

The evolving tariff environment in the United States for 2025 has introduced an additional layer of strategic complexity for manufacturers and procurement teams operating in global supply chains. Tariff adjustments affect the landed cost profile of components such as precision magnets, specialty bearings, and electronic control modules, which are frequently sourced across multiple jurisdictions. Consequently, device developers are reassessing sourcing strategies, balancing cost containment with the need to preserve high-quality supply lines and mitigate risks to production continuity.

In response, many organizations are accelerating localization of critical component supply, redesigning assemblies to reduce dependence on tariff-sensitive inputs, and engaging in scenario planning to maintain predictable production ramp-up. Procurement leaders are increasingly prioritizing multi-sourcing arrangements and flexible manufacturing agreements to absorb tariff volatility. At the same time, regulatory submissions and clinical trial budgets require recalibration to reflect shifting cost structures, underscoring the need for integrated commercial and operational planning that anticipates policy-driven supply chain changes.

Multidimensional segmentation analysis revealing critical design and clinical evidence priorities across applications, end users, and flow architectures

Segmentation insights reveal nuanced demand drivers and design imperatives across clinical applications, end users, and flow architectures. Based on application, clinical deployment spans cardiopulmonary bypass scenarios-differentiated for adult, neonatal, and pediatric patients-extracorporeal membrane oxygenation settings with venoarterial and venovenous configurations, and ventricular assist device use that addresses biventricular, left ventricular, and right ventricular support needs. These distinctions demand scalable pump geometries, adaptable control profiles, and tailored hemocompatibility strategies to meet age- and physiology-specific requirements.

When considering end users, adoption dynamics vary between ambulatory surgery centers, hospitals, and research institutes; within hospitals, demand is further split across cardiac specialty centers, general hospitals, and teaching hospitals, each with distinct procurement cycles, clinical expertise, and evidence expectations. Flow mode segmentation also guides engineering and clinical decisions: continuous flow designs are implemented across axial, centrifugal, and mixed flow formats, while intermittent flow remains relevant for certain procedural contexts and pulsatile flow options include both dual chamber and single chamber architectures. Appreciating these layered segmentations enables product roadmaps and clinical evidence programs to align precisely with user needs and procedural workflows.

How regional regulatory landscapes, clinical infrastructure, and procurement ecosystems across three major geographies drive differentiated adoption strategies

Regional dynamics shape clinical adoption, regulatory strategy, and supply chain decisions in distinct ways across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, concentration of specialized cardiac centers and established reimbursement frameworks support early clinical adoption and device iteration, while commercial teams often collaborate closely with large hospital networks to drive pilot implementations and post-market registries. This region's intensive clinical infrastructure facilitates rapid accumulation of real-world evidence necessary for iterative device improvements.

Europe Middle East & Africa markets present heterogeneous regulatory and reimbursement landscapes, where national pathways and regional harmonization efforts influence time-to-market and adoption patterns; partnerships with academic teaching hospitals and specialty centers are often critical for clinical validation. In Asia-Pacific, rapid growth in cardiac care capacity, increasing investment in domestic manufacturing, and diverse clinical demand profiles create both opportunities and operational complexity. Manufacturers must therefore tailor regulatory strategies, training programs, and distribution models to regional nuances to ensure successful deployment and sustained clinical support.

Competitive dynamics driven by a balance of incumbent scale, focused innovation, and partnerships that unify hardware, software, and clinical support capabilities

Competitive positioning in this technology space is characterized by a mix of incumbent medical device manufacturers, specialized pump innovators, and agile start-ups translating magnetic levitation advances into clinically viable platforms. Established firms leverage scale, broad clinical relationships, and regulatory experience to integrate levitation modules into existing product portfolios, while smaller, focused companies often push design frontiers with novel rotor geometries, control software, and sensor fusion techniques. Across the spectrum, collaboration between industry and academic centers accelerates clinical validation and de-risks early adoption.

Strategic differentiation increasingly depends on the total solution offered-combining the hardware platform with data-rich monitoring, remote diagnostics, and comprehensive training services that reduce clinical burden. Licensing partnerships, co-development agreements, and targeted acquisitions remain common routes to access complementary technologies such as advanced coatings, additive manufacturing for bespoke components, and proprietary control algorithms. Organizations that invest in clear, evidence-based performance claims and scalable clinical support models tend to secure favorable consideration among health systems and specialty centers.

Actionable strategic priorities that integrate product design, evidence planning, and supply chain resilience to accelerate adoption and long-term clinical impact

Industry leaders should prioritize an integrated approach that aligns engineering choices with evidence generation and reimbursement strategy to maximize clinical adoption and long-term impact. First, product development roadmaps must embed hemocompatibility testing, durability protocols, and real-world performance endpoints early in design cycles to reduce downstream regulatory friction. Second, procurement and supply chain teams should develop dual-sourcing strategies and qualify alternative suppliers for tariff-sensitive components to maintain manufacturing continuity and predictable unit economics.

Additionally, commercial strategies should emphasize training and service offerings that reduce procedural complexity for end users and establish strong post-market surveillance. Strategic collaborations with teaching hospitals and high-volume cardiac centers can accelerate clinical learning curves, while modular product architectures and software-enabled features can create recurring revenue opportunities through upgrades and connectivity services. Finally, companies should prepare adaptive regulatory dossiers that reflect regional nuances and support expedited review where possible, thereby shortening the time between clinical validation and widespread adoption.

A mixed-methods approach combining primary clinical engagement, technical validation, and multi-source synthesis to produce actionable, evidence-based insights

The research methodology reflects a mixed-methods approach emphasizing primary clinical input, technical validation, and multi-source synthesis to ensure robust, actionable insights. Primary research included structured interviews and workshops with cardiovascular surgeons, perfusionists, biomedical engineers, hospital procurement leaders, and regulatory specialists to capture real-world performance needs, adoption barriers, and clinical endpoints of interest. These qualitative inputs were complemented by technical reviews of device architectures, control strategies, and hemocompatibility assessments to evaluate engineering trade-offs and failure modes.

Secondary analysis involved systematic review of peer-reviewed clinical literature, device registries, regulatory filings, and patent landscapes to contextualize technological progress and evidentiary trends. Supply chain and policy implications were examined through supplier interviews and publicly available trade documentation to assess sourcing vulnerabilities and tariff impacts. Throughout, triangulation across data sources and iterative validation with subject-matter experts ensured that conclusions reflect both clinical priorities and engineering realities.

Synthesis of clinical and engineering imperatives that chart a clear path from technological promise to sustainable clinical and operational value

In conclusion, fully magnetically levitated blood pump technology presents a compelling pathway to reduce blood trauma, enhance device longevity, and expand therapeutic options across a wide range of clinical applications. The interplay of advanced control electronics, refined flow geometries, and improved materials science supports designs that can meet the heterogeneous needs of adult, neonatal, and pediatric patients across cardiopulmonary bypass, extracorporeal oxygenation, and ventricular assist use cases. As such, the technology is poised to influence both intraoperative and longer-term mechanical circulatory support strategies.

Realizing this potential will require cohesive strategies that integrate clinical evidence generation, resilient supply chain planning, and tailored regional commercialization. Organizations that align engineering roadmaps with clear clinical endpoints, invest in robust post-market data collection, and collaborate closely with high-volume clinical centers will be best positioned to translate technological promise into measurable patient benefits and operational value for health systems.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Fully Magnetically Levitated Blood Pump Market, by Product Type

• 8.1. Ventricular Assist Devices
  • 8.1.1. Left Ventricular Assist Devices
  • 8.1.2. Right Ventricular Assist Devices
  • 8.1.3. Biventricular Assist Devices
• 8.2. Total Artificial Heart Systems
• 8.3. Pediatric Assist Devices
• 8.4. Short-Term Circulatory Support Pumps

9. Fully Magnetically Levitated Blood Pump Market, by Flow Mode

• 9.1. Continuous Flow
  • 9.1.1. Axial
  • 9.1.2. Centrifugal
  • 9.1.3. Mixed Flow
• 9.2. Intermittent Flow
• 9.3. Pulsatile Flow
  • 9.3.1. Dual Chamber
  • 9.3.2. Single Chamber

10. Fully Magnetically Levitated Blood Pump Market, by Application

• 10.1. Cardiopulmonary Bypass
  • 10.1.1. Adult
  • 10.1.2. Neonatal
  • 10.1.3. Pediatric
• 10.2. Extracorporeal Membrane Oxygenation
  • 10.2.1. Venoarterial
  • 10.2.2. Venovenous
• 10.3. Ventricular Assist Device
  • 10.3.1. Biventricular
  • 10.3.2. Left Ventricular
  • 10.3.3. Right Ventricular

11. Fully Magnetically Levitated Blood Pump Market, by End User

• 11.1. Ambulatory Surgery Centers
• 11.2. Hospitals
  • 11.2.1. Cardiac Specialty
  • 11.2.2. General
  • 11.2.3. Teaching
• 11.3. Research Institutes

12. Fully Magnetically Levitated Blood Pump Market, by Region

• 12.1. Americas
  • 12.1.1. North America
  • 12.1.2. Latin America
• 12.2. Europe, Middle East & Africa
  • 12.2.1. Europe
  • 12.2.2. Middle East
  • 12.2.3. Africa
• 12.3. Asia-Pacific

13. Fully Magnetically Levitated Blood Pump Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Fully Magnetically Levitated Blood Pump Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. United States Fully Magnetically Levitated Blood Pump Market

16. China Fully Magnetically Levitated Blood Pump Market

17. Competitive Landscape

• 17.1. Market Concentration Analysis, 2025
  • 17.1.1. Concentration Ratio (CR)
  • 17.1.2. Herfindahl Hirschman Index (HHI)
• 17.2. Recent Developments & Impact Analysis, 2025
• 17.3. Product Portfolio Analysis, 2025
• 17.4. Benchmarking Analysis, 2025
• 17.5. Abbott Laboratories
• 17.6. Abiomed, Inc.
• 17.7. Berlin Heart
• 17.8. BiVACOR Inc.
• 17.9. EUROSETS
• 17.10. Getinge AB
• 17.11. Levitronix, Inc.
• 17.12. LivaNova PLC
• 17.13. magAssist Co., Ltd.
• 17.14. Medos Medizintechnik AG
• 17.15. Medtronic plc
• 17.16. Nikkiso Co., Ltd.
• 17.17. ReliantHeart, Inc.
• 17.18. Sun Medical Technology Research Corp.
• 17.19. Suzhou Tongxin Medical
• 17.20. Terumo Corporation

LIST OF FIGURES

• FIGURE 1. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SHARE, BY KEY PLAYER, 2025
• FIGURE 3. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET, FPNV POSITIONING MATRIX, 2025
• FIGURE 4. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 5. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY FLOW MODE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 7. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 9. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 11. UNITED STATES FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 12. CHINA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

• TABLE 1. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 2. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 3. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 4. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 5. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 6. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
• TABLE 7. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 8. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 9. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 10. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 11. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 12. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 13. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 14. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 15. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 16. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY TOTAL ARTIFICIAL HEART SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 17. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY TOTAL ARTIFICIAL HEART SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 18. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY TOTAL ARTIFICIAL HEART SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 19. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PEDIATRIC ASSIST DEVICES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 20. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PEDIATRIC ASSIST DEVICES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 21. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PEDIATRIC ASSIST DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 22. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY SHORT-TERM CIRCULATORY SUPPORT PUMPS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 23. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY SHORT-TERM CIRCULATORY SUPPORT PUMPS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 24. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY SHORT-TERM CIRCULATORY SUPPORT PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 25. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY FLOW MODE, 2018-2032 (USD MILLION)
• TABLE 26. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CONTINUOUS FLOW, BY REGION, 2018-2032 (USD MILLION)
• TABLE 27. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CONTINUOUS FLOW, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 28. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CONTINUOUS FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 29. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
• TABLE 30. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY AXIAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 31. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY AXIAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 32. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY AXIAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 33. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CENTRIFUGAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 34. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CENTRIFUGAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 35. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CENTRIFUGAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 36. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY MIXED FLOW, BY REGION, 2018-2032 (USD MILLION)
• TABLE 37. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY MIXED FLOW, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 38. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY MIXED FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 39. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY INTERMITTENT FLOW, BY REGION, 2018-2032 (USD MILLION)
• TABLE 40. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY INTERMITTENT FLOW, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 41. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY INTERMITTENT FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 42. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PULSATILE FLOW, BY REGION, 2018-2032 (USD MILLION)
• TABLE 43. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PULSATILE FLOW, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 44. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PULSATILE FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 45. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PULSATILE FLOW, 2018-2032 (USD MILLION)
• TABLE 46. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY DUAL CHAMBER, BY REGION, 2018-2032 (USD MILLION)
• TABLE 47. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY DUAL CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 48. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY DUAL CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 49. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY SINGLE CHAMBER, BY REGION, 2018-2032 (USD MILLION)
• TABLE 50. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY SINGLE CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 51. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY SINGLE CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 52. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 53. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 54. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 55. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 56. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
• TABLE 57. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
• TABLE 58. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 59. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 60. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY NEONATAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 61. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY NEONATAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 62. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY NEONATAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 63. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 64. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 65. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 66. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY REGION, 2018-2032 (USD MILLION)
• TABLE 67. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 68. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 69. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
• TABLE 70. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENOARTERIAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 71. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENOARTERIAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 72. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENOARTERIAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 73. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENOVENOUS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 74. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENOVENOUS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 75. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENOVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 76. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 77. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 78. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 79. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
• TABLE 80. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY BIVENTRICULAR, BY REGION, 2018-2032 (USD MILLION)
• TABLE 81. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY BIVENTRICULAR, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 82. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY BIVENTRICULAR, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 83. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY LEFT VENTRICULAR, BY REGION, 2018-2032 (USD MILLION)
• TABLE 84. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY LEFT VENTRICULAR, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 85. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY LEFT VENTRICULAR, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 86. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY RIGHT VENTRICULAR, BY REGION, 2018-2032 (USD MILLION)
• TABLE 87. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY RIGHT VENTRICULAR, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 88. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY RIGHT VENTRICULAR, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 89. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 90. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 91. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 92. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 93. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 94. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 95. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 96. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 97. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CARDIAC SPECIALTY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 98. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CARDIAC SPECIALTY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 99. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CARDIAC SPECIALTY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 100. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY GENERAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 101. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY GENERAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 102. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY GENERAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 103. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY TEACHING, BY REGION, 2018-2032 (USD MILLION)
• TABLE 104. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY TEACHING, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 105. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY TEACHING, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 106. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 107. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 108. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 109. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 110. AMERICAS FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 111. AMERICAS FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 112. AMERICAS FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
• TABLE 113. AMERICAS FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY FLOW MODE, 2018-2032 (USD MILLION)
• TABLE 114. AMERICAS FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
• TABLE 115. AMERICAS FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PULSATILE FLOW, 2018-2032 (USD MILLION)
• TABLE 116. AMERICAS FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 117. AMERICAS FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
• TABLE 118. AMERICAS FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
• TABLE 119. AMERICAS FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
• TABLE 120. AMERICAS FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 121. AMERICAS FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 122. NORTH AMERICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 123. NORTH AMERICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 124. NORTH AMERICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
• TABLE 125. NORTH AMERICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY FLOW MODE, 2018-2032 (USD MILLION)
• TABLE 126. NORTH AMERICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
• TABLE 127. NORTH AMERICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PULSATILE FLOW, 2018-2032 (USD MILLION)
• TABLE 128. NORTH AMERICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 129. NORTH AMERICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
• TABLE 130. NORTH AMERICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
• TABLE 131. NORTH AMERICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
• TABLE 132. NORTH AMERICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 133. NORTH AMERICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 134. LATIN AMERICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 135. LATIN AMERICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 136. LATIN AMERICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
• TABLE 137. LATIN AMERICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY FLOW MODE, 2018-2032 (USD MILLION)
• TABLE 138. LATIN AMERICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
• TABLE 139. LATIN AMERICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PULSATILE FLOW, 2018-2032 (USD MILLION)
• TABLE 140. LATIN AMERICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 141. LATIN AMERICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
• TABLE 142. LATIN AMERICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
• TABLE 143. LATIN AMERICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
• TABLE 144. LATIN AMERICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 145. LATIN AMERICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 146. EUROPE, MIDDLE EAST & AFRICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 147. EUROPE, MIDDLE EAST & AFRICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY FLOW MODE, 2018-2032 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PULSATILE FLOW, 2018-2032 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 158. EUROPE FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 159. EUROPE FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 160. EUROPE FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
• TABLE 161. EUROPE FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY FLOW MODE, 2018-2032 (USD MILLION)
• TABLE 162. EUROPE FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
• TABLE 163. EUROPE FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PULSATILE FLOW, 2018-2032 (USD MILLION)
• TABLE 164. EUROPE FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 165. EUROPE FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
• TABLE 166. EUROPE FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
• TABLE 167. EUROPE FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
• TABLE 168. EUROPE FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 169. EUROPE FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 170. MIDDLE EAST FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 171. MIDDLE EAST FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 172. MIDDLE EAST FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
• TABLE 173. MIDDLE EAST FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY FLOW MODE, 2018-2032 (USD MILLION)
• TABLE 174. MIDDLE EAST FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
• TABLE 175. MIDDLE EAST FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PULSATILE FLOW, 2018-2032 (USD MILLION)
• TABLE 176. MIDDLE EAST FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 177. MIDDLE EAST FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
• TABLE 178. MIDDLE EAST FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
• TABLE 179. MIDDLE EAST FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
• TABLE 180. MIDDLE EAST FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 181. MIDDLE EAST FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 182. AFRICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 183. AFRICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 184. AFRICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
• TABLE 185. AFRICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY FLOW MODE, 2018-2032 (USD MILLION)
• TABLE 186. AFRICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
• TABLE 187. AFRICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PULSATILE FLOW, 2018-2032 (USD MILLION)
• TABLE 188. AFRICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 189. AFRICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
• TABLE 190. AFRICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
• TABLE 191. AFRICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
• TABLE 192. AFRICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 193. AFRICA FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 194. ASIA-PACIFIC FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 195. ASIA-PACIFIC FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 196. ASIA-PACIFIC FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
• TABLE 197. ASIA-PACIFIC FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY FLOW MODE, 2018-2032 (USD MILLION)
• TABLE 198. ASIA-PACIFIC FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
• TABLE 199. ASIA-PACIFIC FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PULSATILE FLOW, 2018-2032 (USD MILLION)
• TABLE 200. ASIA-PACIFIC FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 201. ASIA-PACIFIC FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
• TABLE 202. ASIA-PACIFIC FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
• TABLE 203. ASIA-PACIFIC FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
• TABLE 204. ASIA-PACIFIC FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 205. ASIA-PACIFIC FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 206. GLOBAL FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 207. ASEAN FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 208. ASEAN FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 209. ASEAN FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
• TABLE 210. ASEAN FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY FLOW MODE, 2018-2032 (USD MILLION)
• TABLE 211. ASEAN FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
• TABLE 212. ASEAN FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PULSATILE FLOW, 2018-2032 (USD MILLION)
• TABLE 213. ASEAN FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 214. ASEAN FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
• TABLE 215. ASEAN FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
• TABLE 216. ASEAN FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
• TABLE 217. ASEAN FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 218. ASEAN FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 219. GCC FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 220. GCC FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 221. GCC FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
• TABLE 222. GCC FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY FLOW MODE, 2018-2032 (USD MILLION)
• TABLE 223. GCC FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
• TABLE 224. GCC FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PULSATILE FLOW, 2018-2032 (USD MILLION)
• TABLE 225. GCC FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 226. GCC FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
• TABLE 227. GCC FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
• TABLE 228. GCC FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
• TABLE 229. GCC FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 230. GCC FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 231. EUROPEAN UNION FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 232. EUROPEAN UNION FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 233. EUROPEAN UNION FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
• TABLE 234. EUROPEAN UNION FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY FLOW MODE, 2018-2032 (USD MILLION)
• TABLE 235. EUROPEAN UNION FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
• TABLE 236. EUROPEAN UNION FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PULSATILE FLOW, 2018-2032 (USD MILLION)
• TABLE 237. EUROPEAN UNION FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 238. EUROPEAN UNION FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
• TABLE 239. EUROPEAN UNION FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
• TABLE 240. EUROPEAN UNION FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
• TABLE 241. EUROPEAN UNION FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 242. EUROPEAN UNION FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 243. BRICS FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 244. BRICS FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 245. BRICS FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
• TABLE 246. BRICS FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY FLOW MODE, 2018-2032 (USD MILLION)
• TABLE 247. BRICS FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
• TABLE 248. BRICS FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PULSATILE FLOW, 2018-2032 (USD MILLION)
• TABLE 249. BRICS FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 250. BRICS FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
• TABLE 251. BRICS FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
• TABLE 252. BRICS FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
• TABLE 253. BRICS FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 254. BRICS FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 255. G7 FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 256. G7 FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 257. G7 FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
• TABLE 258. G7 FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY FLOW MODE, 2018-2032 (USD MILLION)
• TABLE 259. G7 FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
• TABLE 260. G7 FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PULSATILE FLOW, 2018-2032 (USD MILLION)
• TABLE 261. G7 FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 262. G7 FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
• TABLE 263. G7 FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
• TABLE 264. G7 FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
• TABLE 265. G7 FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 266. G7 FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 267. NATO FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 268. NATO FULLY MAGNETICALLY LEVITATED BLOOD PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 269. NATO FULLY MAGNETICAL